RAPIBLOC 20 mg/2 ml, solution for dilution injectable 5 ampoules of 2 ml
Active ingredients: Landiolol hydrochloride, Landiolol
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only, hospital use
Solution for dilution injectable5 ampoules of 2 mlintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- RAPIBLOC 20 mg/2 mL, solution à diluer injectable
- Pharmaceutical form
- solution à diluer injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- AMOMED PHARMA (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 May 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62521323CIP75502694CIP133400955026945Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LANDIOLOLsolution | 20 mg · un flacon de 2 mL de solution à diluer injectable | SA |
| LANDIOLOLsolution | 18,7 mg · un flacon de 2 mL de solution à diluer injectable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.